# CG Oncology Inc. (CGON)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CGON/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 2.24M | $ -139.26M | $ -104.13M | $ 8.82M | $ 1.03B |
| 2025 | $ 4.14M | $ -164.84M | $ -135.65M | $ 7.02M | $ 752.60M |
| 2024 | $ 1.20M | $ -92.53M | $ -82.98M | $ 238.0K | $ 733.38M |
| 2023 | $ 220.6K | $ -52.08M | $ -49.39M | $ 1.03M | $ 184.79M |
| 2022 | $ 0 | $ -9.37M | $ -7.63M | $ 15.94M | $ 125.18M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.05 |
| Current Ratio | 22.22 |

## Other views

- [Metrics](https://sponda.capital/en/CGON.md)
- [Charts](https://sponda.capital/en/CGON/charts.md)
- [Compare](https://sponda.capital/en/CGON/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.